Statistics about Health, Pharma & Medtech in United States
Statistics
- Cannabis Global, Inc. operating profit 2017-2021
- Exicure net cash 2019-2023
- Exicure operating profit 2019-2023
- Phibro Animal Health total assets 2019-2023
- Exagen Diagnostics operating profit 2019-2023
- Exagen Diagnostics liabilities 2019-2023
- Eterna Therapeutics Inc. revenue 2018-2023
- Exagen Diagnostics revenue 2019-2023
- Exagen Diagnostics total assets 2019-2023
- Sellas Life Sciences operating profit 2019-2023
- Exagen Diagnostics total equity 2019-2023
- Smart For Life operating profit 2021-2023
- Procyon total assets 2019-2023
- Soligenix, Inc. operating profit 2019-2023
- Eterna Therapeutics Inc. net income 2010-2012
- Eterna Therapeutics Inc. liabilities 2019-2023
- Eterna Therapeutics Inc. operating profit 2019-2023
- Eterna Therapeutics Inc. net cash 2019-2023
- Eyenovia revenue 2020-2023
- Sera Prognostics total equity 2019-2023
- Palatin Technologies net cash 2020-2024
- Premier Graphene operating profit 2015-2019
- Reneo Pharmaceuticals operating profit 2020-2023
- Bespoke Extracts gross profit 2019-2023
- Reneo Pharmaceuticals liabilities 2020-2023
- Reneo Pharmaceuticals net cash 2020-2023
- Bespoke Extracts total equity 2019-2023
- Reneo Pharmaceuticals total assets 2020-2023
- Reneo Pharmaceuticals total equity 2019-2023
- Siga Technologies revenue 2019-2023
- Seelos Therapeutics gross profit 2012-2016
- Sangui Biotech gross profit 2018-2022
- Premier Graphene liabilities 2015-2019
- Bespoke Extracts operating profit 2019-2023
- Premier Graphene revenue 2017-2019
- Premier Graphene net income 2011-2015
- Premier Graphene gross profit 2017-2019
- Premier Graphene total equity 2015-2019
- Premier Graphene net cash 2015-2019
- Premier Graphene total assets 2015-2019
- Seelos Therapeutics operating profit 2019-2023
- Sera Prognostics operating profit 2020-2023
- Sangui Biotech operating profit 2018-2022
- Sangamo Therapeutics operating profit 2019-2023
- Bespoke Extracts total assets 2019-2023
- Enzon Pharmaceuticals total equity 2019-2023
- Precision Biosciences net income 2019-2023
- Seelos Therapeutics revenue 2017-2023
- Baudax Bio revenue 2020-2022
- Sangamo Therapeutics net income 2019-2023
- Baudax Bio operating profit 2018-2022
- Baudax Bio net income 2018-2022
- Baudax Bio net cash 2018-2022
- Baudax Bio liabilities 2018-2022
- Pardes Biosciences, Inc. total assets 2020-2022
- Baudax Bio total assets 2018-2022
- Baudax Bio total equity 2018-2022
- Palatin Technologies total assets 2020-2024
- Pardes Biosciences, Inc. total equity 2020-2022
- Enzon Pharmaceuticals total assets 2019-2023
- Sangui Biotech revenue 2018-2022
- Sera Prognostics revenue 2020-2023
- Enzon Pharmaceuticals revenue 2018-2022
- Enzon Pharmaceuticals operating profit 2019-2023
- Bespoke Extracts net cash 2019-2023
- Enzon Pharmaceuticals liabilities 2011-2015
- Bespoke Extracts liabilities 2017-2023
- Enzon Pharmaceuticals net cash 2019-2023
- Bespoke Extracts revenue 2018-2023
- Palatin Technologies total equity 2020-2024
- Sangamo Therapeutics revenue 2019-2023
- Siga Technologies operating profit 2019-2023
- Immune Therapeutics net income 2013-2019
- Exelixis operating profit 2019-2023
- Siga Technologies net cash 2019-2023
- Exact Sciences gross profit 2014-2018
- Sangamo Therapeutics net cash 2019-2023
- Exact Sciences revenue 2019-2023
- Edgewise Therapeutics total equity 2019-2023
- Exact Sciences net income 2019-2023
- Phibro Animal Health revenue 2019-2023
- Edgewise Therapeutics liabilities 2020-2023
- Exact Sciences operating profit 2019-2023
- Exact Sciences total assets 2019-2023
- Exact Sciences liabilities 2019-2023
- Exact Sciences net cash 2019-2023
- Sangui Biotech net cash 2018-2022
- Exact Sciences total equity 2019-2023
- Seelos Therapeutics total assets 2019-2023
- Sera Prognostics total assets 2020-2023
- Procyon revenue 2019-2023
- Sangui Biotech total assets 2018-2022
- Sangamo Therapeutics total assets 2019-2023
- Siga Technologies total assets 2019-2023
- Phibro Animal Health gross profit 2019-2023
- Procyon gross profit 2019-2023
- Seelos Therapeutics total equity 2019-2023
- Exelixis revenue 2019-2023
- Edgewise Therapeutics net cash 2020-2023
- Edgewise Therapeutics net income 2020-2023